InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: Whalatane post# 367450

Tuesday, 01/25/2022 2:45:37 PM

Tuesday, January 25, 2022 2:45:37 PM

Post# of 425648
All great news.

And don't forget a Big Pharma's ability to "correct" this generic problem in the USA with the FDA. A Big Pharma has leverage with the FDA...A small pharma (fry) like AMRN not so much.

See how Biogen was able to get Adhulem approved.

So glad to see Denner on BOD. Our Chairman of the BOD needs to be tossed out ASAP.

Shareholders own the company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News